Zoltan Banki

11PUBLICATIONS
22CO-AUTHORS
Social determinants of healthApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cheminformatics and quantitative structure-activity relationshipsGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 29, 2025
Virucidal Potential of 3,3',4,4',5,5'-Hexahydroxy-trans-Stilbene Against Respiratory Syncytial Virus.

Zoltán Bánki, Leonie Wolf, Brigitte Müllauer

|Aug 20, 2025
Interleukin-12 encoded by the oncolytic virus VSV-GP enhances therapeutic antitumor efficacy by inducing CD8+ T-cell responses with a long-lived effector cell phenotype.

Jasmin Hatami, Krishna Das, Leonie Wolf

|Dec 23, 2023
Antiviral Potential of Azelastine against Major Respiratory Viruses.

Katrin Fischhuber, Zoltán Bánki, Janine Kimpel

|Aug 26, 2022
Six-Month Follow-Up of Immune Responses after a Rapid Mass Vaccination against SARS-CoV-2 with BNT162b2 in the District of Schwaz/Austria.

Zoltán Bánki, Lisa Seekircher, Barbara Falkensammer

|Apr 14, 2022
N-chlorotaurine is highly active against respiratory viruses including SARS-CoV-2 (COVID-19) in vitro.

Michaela Lackner, Annika Rössler, André Volland

|Sep 06, 2021
Differential infection of murine and human dendritic cell subsets by oncolytic vesicular stomatitis virus variants.

Lisa Pipperger, Lydia Riepler, Janine Kimpel

Pageof 2

Frequent Collaborators

2 joint publications

Paul Klenerman

2 joint publications

Dorothee von Laer

2 joint publications

Annika Rössler

2 joint publications

Wegene Borena